Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycoinositolphosphosphingolipids, frequently referred to as basidiolipids in the context of higher mushrooms, are specialized sphingolipids that are essential for the structural integrity of fungal cell membranes. These molecules are characterized by a ceramide core attached to an inositol phosphate group, which is further substituted with various carbohydrate chains that vary between species. Biologically, basidiolipids play a vital role in maintaining the fungal plasma membrane, participating in polarized growth, and mediating intracellular signaling pathways crucial for environmental adaptation and virulence. Because their chemical structure is distinct from mammalian sphingolipids, they are investigated as unique targets for the development of selective antifungal agents, such as inositol phosphorylceramide (IPC) synthase inhibitors like Aureobasidin A. Additionally, basidiolipids possess significant immunomodulatory properties and are being studied as potential vaccine adjuvants and anticancer agents due to their ability to activate innate immunity and stimulate cytokine production. They also act as antigens that can be recognized by human heterophile antibodies, making them relevant for both diagnostic biomarker research and the study of fungal-host interactions.
Inhibition of inositol phosphorylceramide (IPC) synthase or direct binding to the lipid moiety leading to membrane disruption and fungal cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoinositolphosphosphingolipid (GIPSL).